Related by context. All words. (Click for frequent words.) 70 underlying pathophysiology 69 etiologic 69 molecular abnormalities 68 idiopathic pulmonary 68 hereditary predisposition 68 monogenic 68 aetiology 68 familial clustering 67 vascular dysfunction 67 predisposing factor 67 primary hyperparathyroidism 67 genetic loci 67 susceptibility loci 67 pathophysiological mechanisms 66 hemoglobinopathies 66 thrombophilia 66 malignant lymphomas 66 neuropathologic 66 pathogenic mechanisms 66 sonographic appearance 66 aetiological 66 gonococcal 66 diagnostic biomarker 66 antiphospholipid syndrome 66 biochemical abnormalities 66 genetic polymorphisms 65 comorbid depression 65 G6PD deficiency 65 multi factorial disease 65 neuropsychiatric diseases 65 causal pathway 65 Genetic predisposition 65 multicentric 65 extramedullary 65 mycosis fungoides 65 causal pathways 65 Genetic variants 65 prostate cancer CaP 65 mitochondrial disorders 65 predisposing factors 65 clinicopathological 65 neovascularisation 65 etiologies 65 neurocognitive impairment 65 prognostic markers 65 etiological factors 64 pathophysiologic 64 microvascular dysfunction 64 nonalcoholic steatohepatitis NASH 64 myeloproliferative diseases 64 renal scarring 64 subclinical disease 64 genetic determinants 64 metabolic dysfunction 64 hormonal abnormalities 64 fibrosing 64 pleiotropic effects 64 myopathies 64 leiomyomas 64 T1DM 64 imatinib resistance 64 histologic subtype 64 chromosomal rearrangement 64 thromboembolic disease 64 C. trachomatis 64 radiographic findings 64 carotid plaques 64 motor neuron degeneration 64 etiologic agent 64 cardiometabolic disorders 64 recurrent laryngeal nerve 64 immunological mechanisms 64 IntroductionThe 64 myocardial dysfunction 64 atherothrombotic 64 pathophysiological processes 64 Candida infection 64 genetic locus 64 Chlamydia pneumoniae 63 granulomatous 63 physiologic mechanisms 63 etiological 63 potentially modifiable 63 Chronic lymphocytic leukemia 63 antiphospholipid antibodies 63 epithelial tumors 63 pathogenetic 63 neurocognitive deficits 63 hyperacute 63 pharmacologic treatments 63 Cognitive impairment 63 molecular subtypes 63 immune dysregulation 63 autoinflammatory diseases 63 immunocompetent 63 serologic tests 63 sonographic diagnosis 63 prognostic indicators 63 Venous thromboembolism 63 Epstein Barr Virus EBV 63 hepatic cirrhosis 63 cervicitis 63 histological subtype 63 genetic aberrations 63 synovial cells 63 FGFs 63 chronicity 63 nodal metastasis 63 metabolic abnormalities 63 susceptibility locus 63 biopsychosocial 63 endocrine dysfunction 63 nonhereditary 63 gastric cardia 63 diabetic polyneuropathy 63 demyelinating 63 biologic pathways 63 microdeletion 63 hepatic liver 63 cytomegalovirus infection 63 neoplastic lesions 63 thrombo embolic 63 ANCA associated 63 #q# deletion 63 repolarization 63 clinicopathologic 63 LHRH receptor positive 63 metabolic abnormality 63 gastric adenocarcinoma 62 polyarticular 62 cAMP pathway 62 IPAH 62 hyperinsulinism 62 paraneoplastic 62 bone marrow mesenchymal stem 62 diathesis 62 urothelial cancer 62 connective tissue diseases 62 obesity insulin resistance 62 colorectal carcinogenesis 62 pulmonary metastases 62 myeloproliferative 62 arterial calcification 62 Magnesium deficiency 62 asplenia 62 meningeal 62 atherogenesis 62 pharmacological approaches 62 enterocolitis 62 HLA DQ2 62 urolithiasis 62 polycythemia vera PV 62 neurological manifestations 62 ABCB1 62 Squalamine 62 melanocortin receptor 62 Leukemias 62 ALI ARDS 62 JAK mutations 62 Pseudomonas aeruginosa infections 62 synaptogenesis 62 neurosensory 62 cerebral vasospasm 62 eating disorders anorexia nervosa 62 Eisenmenger syndrome 62 commonest cause 62 genomic biomarker 62 Sjögren syndrome 62 comorbid disorders 62 Mitochondrial dysfunction 62 hamartoma 62 ERK signaling 62 astrocytomas 62 SSc 62 underlying molecular mechanisms 62 hypertension cardiovascular disease 62 epithelial barrier 62 ALK inhibitors 62 Glucocorticoids 62 atherothrombosis 62 neuropsychological impairments 62 missense mutations 62 pathophysiological 62 keloid scars 62 neuro degenerative disorders 62 hypercalciuria 62 Prognostic factors 62 GH deficiency 62 pharmacologic intervention 62 stratifying patients 62 coinfection 62 colorectal adenoma 62 TTR amyloidosis 62 hyperoxaluria 62 pulmonary hypertension PH 62 Psychiatric disorders 62 multisystem disease 62 neuropsychiatric illnesses 62 metabolic disturbances 62 molecular determinants 62 nonmelanoma 62 pulmonary hypoplasia 62 Sezary syndrome 62 gene locus 62 nonischemic 62 pharmacological therapies 62 spongiform encephalopathies 62 multisystemic 62 cervical lymph nodes 62 somatoform disorders 62 differential gene expression 62 degenerative neurological diseases 62 MELAS syndrome 62 idiopathic myelofibrosis 62 arrhythmogenic 62 cofactors 62 renal fibrosis 61 causative agents 61 varicella infection 61 postoperative AF 61 prostate carcinogenesis 61 Chronic pancreatitis 61 herpesviruses 61 oncogenesis 61 torsade de pointes 61 connective tissue disorders 61 esophagogastric 61 tumor subtypes 61 gene loci 61 microscopic colitis 61 epilepsies 61 rheumatic disorders 61 lipodystrophy syndrome 61 esophageal gastric 61 pathophysiologic mechanism 61 longitudinal cohort study 61 Subtypes 61 thromboemboli 61 prognostic significance 61 bullous 61 MYCN amplification 61 endophenotypes 61 chronic periodontitis 61 bone metabolism 61 angiographically 61 abnormal lipids 61 hypothalamic pituitary 61 intracellular bacteria 61 SIADH 61 RNAi therapeutic targeting 61 gene rearrangements 61 metastatic neuroendocrine tumors 61 anticholinergic agents 61 BPS IC 61 tumor histology 61 pre malignant lesions 61 pathophysiologic mechanisms 61 testicular tumors 61 atypical hemolytic uremic syndrome 61 chronic renal disease 61 papillary renal cell carcinoma 61 bicuspid aortic valves 61 pathological hallmarks 61 teratogens 61 abnormal vaginal bleeding 61 chorioamnionitis 61 functional gastrointestinal disorders 61 airway hyperresponsiveness 61 lipid abnormalities 61 de novo mutations 61 paraganglioma 61 metastatic lymph nodes 61 immunopathology 61 Fibroblast 61 decompensated cirrhosis 61 Vitamin D insufficiency 61 Akt inhibitor 61 Inflammatory bowel diseases 61 gene polymorphisms 61 anemias 61 familial polyposis 61 poststroke depression 61 GBA mutations 61 haematologic 61 prophylactic cranial irradiation 61 allograft rejection 61 neuritic 61 lysosomal storage disease 61 aerodigestive tract 61 alexithymia 61 APOE genotype 61 hypothalamic pituitary adrenal axis 61 multifactorial 61 coronary artery atherosclerosis 61 carcinoids 61 idiopathic pulmonary arterial hypertension 61 bronchial epithelial cells 61 valvular heart 61 transthyretin amyloidosis 61 recurrent miscarriage 61 orchitis 61 modifier genes 61 inherited predisposition 61 cholestasis 61 giant cell arteritis 61 vascular endothelial dysfunction 61 arteritis 61 cranial irradiation 61 disseminated intravascular coagulation DIC 61 polymorphic ventricular tachycardia 61 gastrointestinal stromal tumors GISTs 61 nasal polyposis 61 gastro esophageal reflux 61 chronic myocardial ischemia 61 neuroendocrine cancers 61 chromosome #p#.# 61 carcinoid tumors 61 gastro oesophageal reflux 61 autistic enterocolitis 61 anti angiogenic drugs 61 cryptogenic 61 Chronic inflammation 61 airway remodeling 61 molecular biomarkers 61 seminomas 61 psychiatric comorbidities 61 underdiagnosis 61 BCL#A 61 beta1 integrin 61 Posttraumatic stress disorder 61 herpes simplex encephalitis 61 metastatic uveal melanoma 61 fibrotic disease 61 C. pneumoniae 61 autonomic dysfunction 61 fibrotic lung 61 rifamycins 61 gastric carcinoma 61 Langerhans cell histiocytosis 61 artery stenosis 61 metaplasia 61 valvular heart disease 61 S. maltophilia 61 Decompensated 61 intracranial hypertension 61 vesicoureteral reflux 61 Hereditary angioedema 61 spontaneous regression 61 ABL1 61 atherosclerotic coronary 61 sinonasal 60 clefting 60 skeletal metastases 60 hypertension hypercholesterolemia 60 bronchogenic carcinoma 60 preoperative diagnosis 60 genomic alterations 60 HIV HCV coinfected 60 breast cancer subtypes 60 nongenetic 60 inflammatory bowel syndrome 60 Excessive daytime sleepiness 60 thyroid dysfunction 60 carcinomatosis 60 TCF#L# gene 60 myocardial infarction congestive heart 60 Hashimoto thyroiditis 60 pathognomonic 60 Estrogen Receptor 60 venous malformations 60 murine model 60 prostate cancer PCa 60 immunomodulation 60 systemic amyloidosis 60 viral etiology 60 muscular dystrophies 60 aromatase inhibitors AIs 60 maturational 60 serous ovarian cancer 60 clade B 60 juvenile idiopathic arthritis 60 distinct subtypes 60 motor neuron diseases 60 antibody mediated 60 Malignancies 60 murine models 60 superior mesenteric artery 60 polycythemia vera essential thrombocythemia 60 suppurative 60 riociguat 60 pretransplant 60 reproductive tract infections 60 clonal expansion 60 colorectal adenocarcinoma 60 epigenetic mechanisms 60 glial tumors 60 cystic kidney 60 peripartum 60 subclinical atherosclerosis 60 tumor subtype 60 mesenteric 60 aneuploidies 60 atheromatous 60 neuroactive 60 cAMP signaling 60 renal cysts 60 atopic disorders 60 Enzastaurin 60 N. gonorrhoeae 60 virulence determinants 60 mammary stem cells 60 SCN1A 60 genetic syndromes 60 pyelonephritis 60 neurobiological mechanisms 60 Colon polyps 60 kidney urologic 60 genetic polymorphism 60 hypercoagulable 60 microchimerism 60 neurogenic 60 lysosomal storage diseases 60 narcolepsy cataplexy 60 cathepsins 60 DNA methylation patterns 60 myofascial pain syndrome 60 testicular germ cell 60 Left ventricular hypertrophy 60 ConclusionThis 60 receptor tyrosine kinase inhibitor 60 Diabetic nephropathy 60 Neurodegenerative diseases 60 IgA deficiency 60 cutaneous lesions 60 somatic mutations 60 hyperresponsiveness 60 comorbid anxiety 60 prognostic biomarker 60 presymptomatic 60 induced hepatotoxicity 60 thiopurine 60 environmental toxicants 60 neurologic disorders 60 susceptibility alleles 60 hypogonadotropic hypogonadism 60 pulmonary metastasis 60 Alequel 60 lipomas 60 LVNC 60 Erythropoietic 60 heritable diseases 60 quasispecies 60 neurosyphilis 60 molecularly defined 60 fluoroquinolone resistance 60 coagulopathy 60 plasma kallikrein 60 bacterial parasitic 60 mechanistic studies 60 immune modulating 60 Lymph node 60 nonalcoholic steatohepatitis 60 functional polymorphism 60 polymicrobial 60 thrombotic complications 60 type2 diabetes 60 urethritis 60 atopic diseases 60 untreated celiac disease 60 obstructive coronary 60 pituitary adenomas 60 pulmonary toxicity 60 PKC inhibitors 60 granulosa cell 60 Etiology 60 multifactorial disease 60 neuronal dysfunction 60 retinal vascular 60 pain syndromes 60 cystic lesions 60 Pneumocystis carinii pneumonia 60 Accurately identifying 60 tumor necrosis 60 opportunistic pathogen 60 erythropoietic 60 susceptibility gene 60 mutant huntingtin protein 60 Autoimmune hepatitis 60 Intussusception 60 Thyroid disorders 60 lichen planus 60 levodopa induced 60 ATTR CM 60 pheochromocytoma 60 AT1R 60 MMP inhibitors 60 cerebral microbleeds 60 abnormal pap smears 60 allergic airway inflammation 60 ORMDL3 60 neurobiological basis 60 Leydig cell 60 mediated inhibition 60 potent inhibitors 60 Genetic variations 60 autoimmune pancreatitis 60 biologic plausibility 60 chronic obstructive airway 60 euthymic patients 60 malignant phenotype 60 mitochondrial toxicity 60 lymphoid cells 60 adenomatous polyps 60 microdeletions 60 paragangliomas 60 molecular mechanisms underlying 60 PTEN mutations 60 T1c 60 hyperinsulinemic 60 bronchopulmonary dysplasia BPD 60 etiology 60 epithelial tissues 60 C1q 60 hypertension diabetes mellitus 60 basal cell carcinoma BCC 60 Vitamin B# deficiency 60 prognostic marker 60 nonhuman primate model 60 hepatic lesions 60 neuro developmental disorders 60 isotypes 60 transfusion syndrome 60 Androgens 60 phenotypic expression 60 xenobiotic 60 hamartomas 60 Hypertrophic 60 eczema asthma 60 Churg Strauss syndrome 60 Atypical antipsychotics 60 prognostic indicator 60 clinically heterogeneous 60 membranous nephropathy 59 Aortic stenosis 59 Idiopathic 59 nonbacterial prostatitis 59 lymphoproliferative disorder 59 SE alleles 59 Iron deficiency anemia 59 germline mutations 59 Surgical resection 59 druggable targets 59 ocular inflammatory 59 prognostically 59 Brugada syndrome 59 kinase inhibition 59 hyperplastic 59 BRCA1 BRCA2 59 antiplatelet medications 59 atelectasis 59 infective endocarditis 59 Singh Manoux 59 basal cell nevus syndrome 59 thyroid hormone deficiency 59 ocular disorders 59 electrophysiologic 59 squamous cell lung cancer 59 predictive biomarkers 59 Prenatal diagnosis 59 Urinary tract 59 anti angiogenic agents 59 focal segmental glomerulosclerosis FSGS 59 Trichomonas vaginalis 59 hyperhomocysteinemia 59 node metastasis 59 rheumatologic 59 VCFS 59 MAPK pathway 59 tumorigenicity 59 EBV infection 59 Heavy menstrual bleeding 59 nondemented 59 comorbid psychiatric disorders 59 cellular pathways 59 channelopathies 59 bacteraemia 59 atherothrombotic disease 59 immunodeficiency disorders 59 DVT PE 59 cystic fibrosis chronic pancreatitis 59 metaanalysis 59 bronchoalveolar 59 chromosome aberrations 59 neoplasias 59 Nonspecific 59 epididymitis 59 Endocarditis 59 allergic dermatitis 59 syndromal 59 neuroinflammation 59 syndrome OSAS 59 diagnostic modality 59 portal vein thrombosis 59 rheumatic disease 59 macrovascular events 59 axonal degeneration 59 chlamydial 59 fluconazole resistant 59 fungal colonization 59 virally induced 59 inhaled bronchodilators 59 neurobiological underpinnings 59 PPARγ 59 unknown etiology 59 prognostic variables 59 dystrophies 59 gastroduodenal 59 variceal bleeding 59 ventricular myocardium 59 incidentalomas 59 Endothelial dysfunction 59 c myc gene 59 epilepsy Parkinson disease 59 KRAS oncogene 59 familial aggregation 59 thetreatment 59 metabolomic profiles 59 osteochondroma 59 Cognitive dysfunction 59 post transplant lymphoproliferative 59 nutrient supplementation 59 autistic regression 59 small molecule activators 59 melanocytic 59 developmental neurotoxicity 59 impaired glucose metabolism 59 hyperalgesia 59 Hutchinson Gilford progeria 59 trophoblastic 59 follicular dendritic cells 59 autopsied brains 59 cervical neoplasia 59 pharmacological interventions 59 IDH mutations 59 calculi 59 Opportunistic infections 59 candida infections 59 leukoencephalopathy 59 familial predisposition 59 MGUS 59 GSK3B 59 prostate carcinomas 59 antithrombotic agents 59 phenothiazines 59 NFTs 59 GPC5 59 hormonal disorders 59 SGLT2 inhibitors 59 nonmetastatic 59 oesophageal adenocarcinoma 59 pseudotumor 59 Skeletal muscle 59 P aeruginosa 59 obstructive coronary artery 59 intracerebral 59 myocardial fibrosis 59 juvenile idiopathic arthritis JIA 59 Epstein Barr virus EBV 59 syndromic 59 Polycythemia vera 59 arteriography 59 CP CPPS 59 perioperative complications 59 dentinal hypersensitivity 59 monogenic disorders 59 glomerulonephritis 59 lymphatic vasculature 59 PCOD 59 tissue fibrosis 59 hemorrhagic cystitis 59 asymptomatic bacteriuria 59 Non Hodgkin lymphomas 59 hyper responsiveness 59 Diabetic neuropathy 59 extrapulmonary disease 59 serum retinol 59 pathogenetic mechanisms 59 NMDA antagonists 59 SMAD4 59 dysglycemia 59 parkinsonian 59 steroidogenesis 59 histologically proven 59 aberrant activation 59 herpes zoster shingles 59 proliferative diseases 59 von Hippel Lindau 59 Dysregulation 59 Propionibacterium acnes 59 hematopoietic cancers 59 thyrotoxicosis 59 Candidiasis 59 Histologically 59 precursor lesions 59 Lymphocytic 59 hemorrhagic complications 59 venous thromboembolic disease 59 ischemic mitral regurgitation 59 sCJD 59 periodontal tissues 59 Helicobacter pylori infection 59 obstetric complications 59 antiproliferative effects 59 breast endometrial 59 IGF IR 59 colonoscopic 59 thyroid deficiency 59 cardiac fibrosis 59 antenatal depression 59 chromosomal alterations 59 causative mutation 59 Brodmann Area 59 NPHP 59 ADAMTS# 59 vascular occlusion 59 pharmacologic agents 59 biomarker identification 59 carotid atherosclerosis 59 HBV genotypes 59 candidemia 59 leptin deficiency 59 neuropsychiatric disorder 59 circadian genes 59 BEXXAR Therapeutic Regimen 59 Zollinger Ellison Syndrome 59 serologic testing 59 OSAHS 59 proliferative disorders 59 Genetic susceptibility 59 veno occlusive disease 59 ABO blood 59 Sleep disordered breathing 59 anticonvulsant medications 58 monoclonal gammopathy 58 neuroregenerative 58 mitochondrial mutations 58 thyroid nodules 58 choroidal neovascularization 58 histological subtypes 58 epigenetic regulation 58 biochemical imbalances 58 Severe Primary IGFD 58 adenomyosis 58 corticosteroid induced 58 epigenetic modification 58 lupus multiple sclerosis 58 haematological malignancies 58 K ras mutations 58 mediastinitis 58 primary biliary cirrhosis 58 infantile hemangioma 58 asthma rhinitis 58 gastric varices 58 RET PTC rearrangements 58 childhood leukemias 58 metabolic alterations 58 lymphocytic 58 rheumatoid arthritis lupus 58 myelofibrosis polycythemia vera 58 AGGRASTAT R tirofiban hydrochloride 58 myeloproliferative neoplasms 58 antiepileptics 58 treatmentof 58 nanobacteria 58 renal biopsy 58 dominantly inherited 58 colonic motility 58 rheumatological 58 MELAS 58 adenomatous 58 PCNSL 58 chromosomal regions 58 periodontal infections 58 CYP#D# gene 58 β blockers 58 polymyalgia rheumatica 58 Beta thalassemia 58 congenita 58 urothelial carcinoma 58 lupus scleroderma 58 cutaneous lupus 58 dysgenesis 58 Ischemic 58 adjuvant therapies 58 endobronchial 58 ATG#L# 58 pathological hallmark 58 arthropathy 58 osteosarcomas 58 Fas ligand 58 atopic sensitization 58 atherosclerotic vascular disease 58 Clostridia 58 somatic symptoms 58 osteoid osteoma 58 Periodontitis 58 secondary amenorrhea 58 COL#A# 58 chronic thromboembolic pulmonary 58 psychosocial stressors 58 neurocognitive dysfunction 58 vertebral subluxation 58 pretreatment serum 58 dietary interventions 58 Barrett esophagus BE 58 GABAA receptors 58 spinal metastases 58 Bardet Biedl Syndrome 58 meta analytic review 58 intestinal permeability 58 Endometrial cancer 58 autoimmune thyroiditis 58 sclerosing 58 Henoch purpura 58 Incretin mimetics 58 intranasal corticosteroids 58 Liver transplantation 58 obese postmenopausal 58 Metastases 58 erythema nodosum 58 receptor subtypes 58 allogeneic HSCT 58 transgenic mouse models 58 lipohypertrophy 58 liver metastasis 58 Interstitial cystitis 58 silent myocardial ischemia 58 Neoplasms 58 transplantation HCT 58 chronic inflammations 58 hyperuricaemia 58 hydrops 58 primary spontaneous pneumothorax 58 tumoral 58 excitotoxic 58 benign thyroid nodules 58 Compulsive hoarding 58 lung fibrosis 58 Genetic variation 58 cerebrovascular accidents 58 causative mutations 58 prenatal exposures 58 nephrogenic 58 therapeutic modalities 58 prospective multicenter study 58 hepatic fibrosis 58 SIBO 58 p# mutations 58 potent inducer 58 hyper IgE syndrome 58 neurologic diseases 58 SNP rs# [001] 58 exocrine glands 58 NS3 protease 58 hormonal deficiencies 58 metabolic syndromes 58 Oxidative damage 58 Predisposition 58 polymicrobial infections 58 MTHFD1L gene 58 protein tyrosine phosphatase 58 vWD 58 PON1 58 apoptotic pathway 58 bladder dysfunction 58 Sclerosing 58 hypereosinophilic syndrome 58 Mitral valve 58 mGluR2 NAM 58 Hemangiomas 58 isoenzymes 58 insulin resistance syndrome 58 obscure gastrointestinal bleeding 58 intracerebral haemorrhage 58 N glycan 58 diabetes mellitus hypertension 58 node metastases 58 inherited mutations 58 pulmonary alveolar 58 menstrual disorders 58 benign prostatic hypertrophy BPH 58 dermatologic diseases 58 cerebral cortical 58 esophageal reflux 58 supratentorial 58 psychostimulant 58 androgen excess 58 Nonalcoholic fatty liver 58 multiplex assay 58 radioimmunotherapy RIT 58 immunodeficiency diseases 58 maladaptive behaviors 58 ADPKD 58 EGFR tyrosine kinase inhibitors 58 Non Alcoholic Fatty 58 signaling cascades 58 autosomal recessive disease 58 therapeutic regimens 58 psychiatric comorbidity 58 Lyme arthritis 58 variant angina 58 neurosteroid 58 hepato 58 hypervascular tumors 58 crohn disease 58 Fatty liver 58 TSH receptor 58 Deforolimus 58 herpetic 58 heparin induced thrombocytopenia 58 chemoprevention trials 58 γδ T cells 58 CTEPH 58 FGFR2 58 nerve degeneration 58 protein misfolding diseases 58 Necrotizing fasciitis 58 retrovirus XMRV 58 genetic susceptibilities 58 Myocardial infarction 58 metabolizing enzymes 58 osteoid 58 hyperinsulinemia 58 biliary obstruction 58 Hypoglycaemia 58 Apolipoprotein E 58 post thrombotic syndrome 58 β thalassemia 58 deep vein thromboses 58 immunosuppressed patients 58 amnestic 58 prospective longitudinal 58 nucleolar 58 arterial hypertension 58 chromosomal anomalies 58 confounder 58 Exclusion criteria 58 stimulate neurogenesis 58 hemodilution 58 ß blockers 58 morbidities 58 aortic atherosclerosis 58 essential thrombocythemia 58 pancreatic ductal adenocarcinoma 58 VADT 58 leaky gut 58 induced cardiomyopathy 58 Huntingtons disease 58 biologic pathway 58 PARP inhibition 58 microangiopathy 58 diabetic microvascular complications 58 lung epithelium 58 benign positional vertigo 58 mtDNA mutations 58 Legg Calvé Perthes disease 58 urogenital infections 58 KRAS mutational status 58 amyloid plaque formation 58 acute myeloid 58 CB2 receptor 58 lung cancer chemoprevention 58 gene deletions 58 Pulmonary hypertension 58 respiratory pathogens 58 vesicular 58 mTOR inhibitors 58 hyperparathyroidism 58 hypoxic tumors 58 Raynaud syndrome 58 candidiasis 58 beta globin gene 58 recurrent DVT 58 teratoma 58 gastric carcinomas 58 acetabular fractures 58 genes differentially expressed 58 signal transduction inhibitors 58 multiorgan 58 Meningiomas 58 mucinous 58 pancreatic endocrine 58 MYH9 58 bladder carcinoma 58 neurologic symptoms 58 syndromes 58 nasopharyngeal carcinoma 58 genes predisposing 58 peroxisomal